Global Pigmentation Disorder Therapeutics Market 2018-2022 - Increasing Investment to Meet Skin Health Needs to Spur Growth - Technavio
LONDON--(BUSINESS WIRE)--Oct 9, 2018--The global pigmentation disorder therapeutics market 2018-2022 is expected to post a CAGR of close to 7% during the forecast period, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181009005522/en/
Technavio analysts predict the global pigmentation disorder therapeutics market to post a CAGR of close to 7% by 2022. (Photo: Business Wire)
A key factor driving the growth of the market is increasing investment to meet skin health needs. People across the world are concerned about their skin and appearance. Many people are opting for skin-related treatments to improve their skin and avoid damage to the skin. This is providing huge development goals for companies and is encouraging vendors to invest huge amounts of money in this field.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the development of safe products for the treatment of pigmentation as one of the key emerging trends in the global pigmentation disorder therapeutics market:
Global pigmentation disorder therapeutics market: Development of safe products for the treatment of pigmentation
The increase in the prevalence of pigmentation disorders is driving the demand for skin lightening products for the treatment of pigmentation. These products contain up to 2% of hydroquinone. It has been observed that hydroquinone reduces pigmentation.
“Continuous research is being conducted on contents that can be used for manufacturing products for the treatment of pigmentation. Pigmentation can be reduced by regulating the tyrosinase enzyme. This can be done by slowing down its activity or competing for its substrates, either tyrosine in step one or L-DOPA in step two,” says a senior analyst at Technavio for research on infectious and rare diseases.
Global pigmentation disorder therapeutics market: Segmentation analysis
This market research report segments the global pigmentation disorder therapeutics market by products (hyperpigmentation and hypopigmentation) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of more than 43%, followed by APAC and EMEA respectively. The region is expected to continue to dominate the market during the forecast period.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181009005522/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/09/2018 10:03 AM/DISC: 10/09/2018 10:03 AM